XML 146 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and contingencies
 6 Months Ended
Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and contingencies Commitments and contingencies
Leases
The table below presents the lease-related assets and liabilities recorded on the consolidated balance sheet as of September 30, 2022:
Three Months Ended September 30,Six Months Ended September 30,
2022202120222021
Lease cost
Finance lease costs:
Amortization of right-to-use asset$607 $607 $1,214 $1,214 
Interest on lease liabilities550 557 1,102 1,115 
Operating lease costs252 245 511 487 
Total lease cost$1,409 $1,409 $2,827 $2,816 
The following table summarizes the classification of lease costs in the consolidated statement of operations for the three months ended September 30, 2022 and 2021 as follows:
Three Months Ended September 30,Six Months Ended September 30,
2022202120222021
Finance Lease Costs
   Research and development$518 $518 $1,035 $1,035 
   Selling, general and administrative89 89 179 179 
Other income (expense)550 557 1,102 1,115 
Operating Lease Costs
Research and development103 95 213 189 
   Selling, general and administrative149 150 298 298 
Total lease cost$1,409 $1,409 $2,827 $2,816 
The following table summarizes the maturity of the Company's lease liabilities on an undiscounted cash flow basis and a reconciliation to the operating and financing lease liabilities recognized on its balance sheet as of September 30, 2022:
September 30, 2022
Operating leasesFinancing leaseTotal
2023 (remaining six months)$500 $1,297 $1,797 
20241,007 2,639 3,646 
20251,016 2,718 3,734 
20261,026 2,799 3,825 
2027997 2,883 3,880 
Thereafter2,755 38,022 40,777 
Total lease payments7,301 50,358 57,659 
Less: interest2,019 23,552 25,571 
Total lease liabilities$5,282 $26,806 $32,088 
The following table provides lease disclosure as of September 30, 2022 and March 31, 2022:
September 30, 2022March 31, 2022
Leases
Right-to-use operating lease asset$4,984 $5,552 
Right-to-use finance lease asset40,879 42,094 
Total lease assets$45,863 $47,646 
Operating lease liabilities, current$1,002 $1,070 
Finance lease liabilities, current2,600 2,562 
Operating lease liabilities, non-current4,280 4,801 
Finance lease liabilities, non-current24,206 24,406 
Total lease liabilities$32,088 $32,839 
The following table provides lease disclosure for the three months ended September 30, 2022 and 2021:
Six Months Ended September 30,
20222021
Other information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$466 $487 
Operating cash flows from finance leases$1,102 $1,115 
Financing cash flows from finance leases$163 $114 
Weighted-average remaining lease term - operating leases7.1years8.3years
Weighted-average remaining lease term - financing leases16.8years17.8years
Weighted-average discount rate - operating leases9.8 %9.8 %
Weighted-average discount rate - financing leases8.3 %8.3 %
The variable lease costs and short-term lease costs were insignificant for three and six months ended September 30, 2022 and 2021.
Manufacturing commitments
The Company has entered into an agreement with a contract manufacturing organization to provide clinical trial products. As of September 30, 2022 and March 31, 2022, the Company had committed to minimum payments under these arrangements totaling $1,209 and $1,951, respectively.
Indemnification agreements
In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, business partners and other parties with respect to certain matters including, but not limited to, losses arising out of breach of such agreements or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with members of its executive management team and its board of directors that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. To date, the Company has not incurred any material costs as a result of such indemnifications. The Company is not aware of any claims under indemnification arrangements, and therefore it has not accrued any liabilities related to such obligations in its consolidated financial statements as of September 30, 2022 or March 31, 2022.
Legal proceedings
The Company is not a party to any litigation and does not have contingency reserves established for any litigation liabilities.